Review
"Poor-risk" germ cell tumors: current progress and future directions
Affiliations
- PMID: 1372761
Item in Clipboard
Review
"Poor-risk" germ cell tumors: current progress and future directions
Semin Oncol.
1992 Apr.
No abstract available
Similar articles
-
Poor prognosis germ cell tumors of the testes: improved results with high dose regimens.Prog Clin Biol Res. 1988;269:419-27. Prog Clin Biol Res. 1988. PMID: 2455910 Clinical Trial. No abstract available.
-
Current chemotherapy strategy in patients with germ cell tumors.Eur Urol. 1993;23 Suppl 2:47-8. doi: 10.1159/000474703. Eur Urol. 1993. PMID: 7685703 No abstract available.
-
Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.N Engl J Med. 1987 Jun 4;316(23):1435-40. doi: 10.1056/NEJM198706043162302. N Engl J Med. 1987. PMID: 2437455 Clinical Trial.
-
[Chemotherapy of disseminated germ cell tumors of the testis].Sov Med. 1987;(11):78-81. Sov Med. 1987. PMID: 2451298 Review. Russian. No abstract available.
-
Chemotherapy for patients with poor prognosis germ cell tumors.World J Urol. 2009 Aug;27(4):471-6. doi: 10.1007/s00345-009-0404-2. Epub 2009 Mar 28. World J Urol. 2009. PMID: 19330334 Review.
Cited by
-
Treatment intensification in disseminated germ-cell tumors.World J Urol. 1994;12(4):207-13. doi: 10.1007/BF00185676. World J Urol. 1994. PMID: 7820143 Review.
-
Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy.Ann Hematol. 1996 Jan;72(1):1-9. doi: 10.1007/BF00663009. Ann Hematol. 1996. PMID: 8605273 Review.